eCFR Reference Browser

---

title: "21 CFR §1304.26"

source: "https://www.ecfr.gov/current/title-21/section-1304.26"

title_number: "21"

volume_number: "9"

chapter_number: "Unknown"

subchapter_code: "Unknown"

subchapter_subject: "Unknown"

part_code: "1304"

part_subject: "RECORDS AND REPORTS OF REGISTRANTS"

subpart_code: "A"

subpart_subject: "General Requirements"

section_number: "1304.26"

section_subject: "Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric acid."

cfr_reference: "21 CFR 1304.26"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Part 1300 to End"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

In addition to the recordkeeping requirements for dispensers and researchers provided in § 1304.22, practitioners dispensing gamma-hydroxybutyric acid that is manufactured or distributed in accordance with an application under section 505 of the Federal Food, Drug, and Cosmetic Act must maintain and make available for inspection and copying by the Attorney General, all of the following information for each prescription:

(a)Name of the prescribing practitioner.

(b)Prescribing practitioner's Federal and State registration numbers, with the expiration dates of these registrations.

(c)Verification that the prescribing practitioner possesses the appropriate registration to prescribe this controlled substance.

(d)Patient's name and address.

(e)Patient's insurance provider, if available.

§1304.26 - Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric acid.